Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Net other income and expenses outside core operations
Percentile
P21
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-35.60M | -12.6% |
| 2024 | $-31.61M | +19.5% |
| 2023 | $-39.26M | +25.7% |
| 2022 | $-52.81M | +25.9% |
| 2021 | $-71.24M | -149.2% |
| 2020 | $144.76M | +485.4% |
| 2019 | $24.73M | -85.8% |
| 2018 | $174.28M | +1543.5% |
| 2017 | $10.60M | +389.1% |
| 2016 | $2.17M | - |